Regulatory iNKT cells lack expression of the transcription factor PLZF and control the homeostasis of T reg cells and macrophages in adipose tissue

Nature Immunology

Volumn 16, Issue 1, 2015, Pages 85-95

  Lynch, Lydia ^a   Michelet, Xavier ^a   Zhang, Sai ^b   Brennan, Patrick J ^a   Moseman, Ashley ^c   Lester, Chantel ^a   Besra, Gurdyal ^d   Vomhof Dekrey, Emilie E ^e   Tighe, Mike ^e   Koay, Hui Fern ^f   Godfrey, Dale I ^f   Leadbetter, Elizabeth A ^e   Sant'Angelo, Derek B ^b,g   Von Andrian, Ulrich ^c   Brenner, Michael B ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^e TRUDEAU INSTITUTE   (United States)

^f UNIVERSITY OF MELBOURNE   (Australia)

^g CHILD HEALTH INSTITUTE OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E4BP4; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR PLZF; TRANSCRIPTION FACTOR T BET; UNCLASSIFIED DRUG; BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; KRUPPEL LIKE FACTOR; NFIL3 PROTEIN, MOUSE; ZBTB16 PROTEIN, MOUSE;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL POPULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EPIDIDYMIS FAT; FEMALE; FLOW CYTOMETRY; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREGULATION; INVARIANT NATURAL KILLER T CELL; LIVER; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MALE; MOUSE; NATURAL KILLER T CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SPLEEN; THYMUS; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL GROWTH; CYTOLOGY; DEFICIENCY; GENE EXPRESSION REGULATION; GENETICS; GERMFREE ANIMAL; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM;

ADIPOSE TISSUE; ANIMALS; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; CELL GROWTH PROCESSES; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HOMEOSTASIS; INTERLEUKIN-10; INTERLEUKIN-2; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MACROPHAGES; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; NATURAL KILLER T-CELLS; SPECIFIC PATHOGEN-FREE ORGANISMS; T-LYMPHOCYTES, REGULATORY;

EID: 84923384136     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.3047     Document Type: Article

References (52)

1. Cohen, N.R., Garg, S., Brenner, M.B. Antigen presentation by CD1 lipids, T cells, and NKT cells in microbial immunity. Adv. Immunol. 102, 1-94 (2009).
2. Savage, A.K. et al. The transcription factor PLZF directs the effector program of the NKT cell lineage. Immunity 29, 391-403 (2008).
3. Kovalovsky, D. et al. The BTB-zinc finger transcriptional regulator PLZF controls the development of invariant natural killer T cell effector functions. Nat. Immunol. 9, 1055-1064 (2008).
4. Martin, E. et al. Stepwise development of MAIT cells in mouse and human. PLoS Biol. 7, e54 (2009).
5. Kreslavsky, T. et al. TCR-inducible PLZF transcription factor required for innate phenotype of a subset of T cells with restricted TCR diversity. Proc. Natl. Acad. Sci. USA 106, 12453-12458 (2009).
6. Watarai, H. et al. Development and function of invariant natural killer T cells producing TH2-and TH17-cytokines. PLoS Biol. 10, e1001255 (2012).
7. Brennan, P.J., Brigl, M., Brenner, M.B. Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions. Nat. Rev. Immunol. 13, 101-117 (2013).
8. Berzins, S.P., Smyth, M.J., Baxter, A.G. Presumed guilty: natural killer T cell defects and human disease. Nat. Rev. Immunol. 11, 131-142 (2011).
9. Godfrey, D.I., Kronenberg, M. Going both ways: immune regulation via CD1d-dependent NKT cells. J. Clin. Invest. 114, 1379-1388 (2004).
10. Novak, J., Griseri, T., Beaudoin, L., Lehuen, A. Regulation of type 1 diabetes by NKT cells. Int. Rev. Immunol. 26, 49-72 (2007).
11. Araki, M. et al. Th2 bias of CD4+ NKT cells derived from multiple sclerosis in remission. Int. Immunol. 15, 279-288 (2003).
12. van der Vliet, H.J. et al. Circulating V(24+) V11+ NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage. Clin. Immunol. 100, 144-148 (2001).
13. Bosma, A., Abdel-Gadir, A., Isenberg, D.A., Jury, E.C., Mauri, C. Lipid-antigen presentation by CD1d+ B cells is essential for the maintenance of invariant natural killer T cells. Immunity 36, 477-490 (2012).
14. Novak, J., Lehuen, A. Mechanism of regulation of autoimmunity by i NKT cells. Cytokine 53, 263-270 (2011).
15. Lynch, L. et al. Invariant NKT cells and CD1d+ cells amass in human omentum and are depleted in patients with cancer and obesity. Eur. J. Immunol. 39, 1893-1901 (2009).
16. Lynch, L. et al. Adipose tissue invariant NKT cells protect against diet-induced obesity and metabolic disorder through regulatory cytokine production. Immunity 37, 574-587 (2012).
17. Lumeng, C.N., DelProposto, J.B., Westcott, D.J., Saltiel, A.R. Phenotypic switching of adipose tissue macrophages with obesity is generated by spatiotemporal differences in macrophage subtypes. Diabetes 57, 3239-3246 (2008).
18. Feuerer, M. et al. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat. Med. 15, 930-939 (2009).
19. Cipolletta, D. et al. PPAR-is a major driver of the accumulation and phenotype of adipose tissue Treg cells. Nature 486, 549-553 (2012).
20. Ji, Y. et al. Activation of natural killer T cells promotes M2 macrophage polarization in adipose tissue and improves systemic glucose tolerance via interleukin-4 (IL-4)/STAT6 protein signaling axis in obesity. J. Biol. Chem. 287, 13561-13571 (2012).
21. Schipper, H.S. et al. Natural killer T cells in adipose tissue prevent insulin resistance. J. Clin. Invest. 122, 3343-3354 (2012).
22. Huh, J.Y. et al. A novel function of adipocytes in lipid antigen presentation to i NKT cells. Mol. Cell. Biol. 33, 328-339 (2013).
23. Weisberg, S.P. et al. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112, 1796-1808 (2003).
24. Lumeng, C.N., Bodzin, J.L., Saltiel, A.R. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Invest. 117, 175-184 (2007).
25. Schipper, H.S. et al. Natural killer T cells in adipose tissue prevent insulin resistance. J. Clin. Invest. 122, 3343-3354 (2012).
26. Ji, Y. et al. Short term high fat diet challenge promotes alternative macrophage polarization in adipose tissue via natural killer T cells and interleukin-4. J. Biol. Chem. 287, 24378-24386 (2012).
27. Hams, E., Locksley, R.M., McKenzie, A.N., Fallon, P.G. Cutting edge: IL-25 elicits innate lymphoid type 2 and type II NKT cells that regulate obesity in Mice. J. Immunol. 191, 5349-5353 (2013).
28. Wright, D.E., Wagers, A.J., Gulati, A.P., Johnson, F.L., Weissman, I.L. Physiological migration of hematopoietic stem and progenitor cells. Science 294, 1933-1936 (2001).
29. Ohteki, T., Maki, C., Koyasu, S., Mak, T.W., Ohashi, P.S. Cutting edge: LFA-1 is required for liver NK1.1+TCR+ cell development: evidence that liver NK1.1+TCR+ cells originate from multiple pathways. J. Immunol. 162, 3753-3756 (1999).
30. Geissmann, F. et al. Intravascular immune surveillance by CXCR6+ NKT cells patrolling liver sinusoids. PLoS Biol. 3, e113 (2005).
31. Thomas, S.Y. et al. PLZF induces an intravascular surveillance program mediated by long-lived LFA-1-ICAM-1 interactions. J. Exp. Med. 208, 1179-1188 (2011).
32. Cohen, N.R. et al. Shared and distinct transcriptional programs underlie the hybrid nature of i NKT cells. Nat. Immunol. 14, 90-99 (2013).
33. Kronenberg, M. Toward an understanding of NKT cell biology: progress and paradoxes. Annu. Rev. Immunol. 23, 877-900 (2005).
34. Bendelac, A., Savage, P.B., Teyton, L. The biology of NKT cells. Annu. Rev. Immunol. 25, 297-336 (2007).
35. Brennan, P.J., Brigl, M., Brenner, M.B. Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions. Nat. Rev. Immunol. 13, 101-117 (2013).
36. Constantinides, M.G., Bendelac, A. Transcriptional regulation of the NKT cell lineage. Curr. Opin. Immunol. 25, 161-167 (2013).
37. Lee, Y.J., Holzapfel, K.L., Zhu, J., Jameson, S.C., Hogquist, K.A. Steady-state production of IL-4 modulates immunity in mouse strains and is determined by lineage diversity of iNKT cells. Nat. Immunol. 14, 1146-1154 (2013).
38. Chang, P.P. et al. Identification of Bcl-6-dependent follicular helper NKT cells that provide cognate help for B cell responses. Nat. Immunol. 13, 35-43 (2012).
39. Motomura, Y. et al. The transcription factor E4BP4 regulates the production of IL-10 and IL-13 in CD4+ T cells. Nat. Immunol. 12, 450-459 (2011).
40. Sakaguchi, S. Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22, 531-562 (2004).
41. Cheng, G. et al. IL-2 receptor signaling is essential for the development of Klrg1+ terminally differentiated T regulatory cells. J. Immunol. 189, 1780-1791 (2012).
42. Monteiro, M. et al. Identification of regulatory Foxp3+ invariant NKT cells induced by TGF-. J. Immunol. 185, 2157-2163 (2010).
43. Moran, A.E. et al. T cell receptor signal strength in Treg and iNKT cell development demonstrated by a novel fluorescent reporter mouse. J. Exp. Med. 208, 1279-1289 (2011).
44. Constantinides, M.G., Picard, D., Savage, A.K., Bendelac, A. A naive-like population of human CD1d-restricted T cells expressing intermediate levels of promyelocytic leukemia zinc finger. J. Immunol. 187, 309-315 (2011).
45. Sag, D., Krause, P., Hedrick, C.C., Kronenberg, M., Wingender, G. IL-10-producing NKT10 cells are a distinct regulatory invariant NKT cell subset. J. Clin. Invest. 124, 3725-3740 (2014).
46. Xu, X. et al. Obesity activates a program of lysosomal-dependent lipid metabolism in adipose tissue macrophages independently of classic activation. Cell Metab. 18, 816-830 (2013).
47. Wu, L., Van Kaer, L. Contribution of lipid-reactive natural killer T cells to obesity-associated inflammation and insulin resistance. Adipocyte 2, 12-16 (2013).
48. Lynch, L. Adipose i NKT cells. Immunology 142, 337-346 (2014).
49. Swann, J., Crowe, N.Y., Hayakawa, Y., Godfrey, D.I., Smyth, M.J. Regulation of antitumour immunity by CD1d-restricted NKT cells. Immunol. Cell Biol. 82, 323-331 (2004).
50. Fontenot, J.D. et al. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22, 329-341 (2005).
51. Dash, P. et al. Paired analysis of TCR and TCR chains at the single-cell level in mice. J. Clin. Invest. 121, 288-295 (2011).
52. Uldrich, A.P. et al. CD1d-lipid antigen recognition by the TCR. Nat. Immunol. 14, 1137-1145 (2013).